Brief: China NT Pharma Group says Xi Di Ke drug has obtained approval from China Food And Drug Administration to enter market
04/01/2017 04:02
Jan 4 (Reuters) - China Nt Pharma Group Co Ltd 1011.HK -
* Xi di ke has obtained approval from china food and drug
administration to enter market
Source text for Eikon: ID:nHKS3zzCnd
Further company coverage: 1011.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY